Atlas Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.58K | Hold |
52
| – | – | ﹤0.01% | 801 |
|
|
2025
Q1 | $6.65K | Hold |
52
| – | – | ﹤0.01% | 831 |
|
|
2024
Q4 | $6.87K | Hold |
52
| – | – | ﹤0.01% | 804 |
|
|
2024
Q3 | $7.57K | Hold |
52
| – | – | ﹤0.01% | 748 |
|
|
2024
Q2 | $7.14K | Hold |
52
| – | – | ﹤0.01% | 762 |
|
|
2024
Q1 | $7.14K | Hold |
52
| – | – | ﹤0.01% | 742 |
|
|
2023
Q4 | $7.06K | Hold |
52
| – | – | ﹤0.01% | 774 |
|
|
2023
Q3 | $6.36K | Hold |
52
| – | – | ﹤0.01% | 747 |
|
|
2023
Q2 | $6.6K | Hold |
52
| – | – | ﹤0.01% | 769 |
|
|
2023
Q1 | $6.72K | Hold |
52
| – | – | ﹤0.01% | 773 |
|
|
2022
Q4 | $6.83K | Hold |
52
| – | – | ﹤0.01% | 765 |
|
|
2022
Q3 | $6.08K | Hold |
52
| – | – | ﹤0.01% | 759 |
|
|
2022
Q2 | $6.12K | Buy |
+52
| New | +$6.12K | ﹤0.01% | 826 |
|
|
2022
Q1 | – | Sell |
-700
| Closed | -$107K | – | 939 |
|
|
2021
Q4 | $107K | Buy |
700
+300
| +75% | +$45.8K | 0.02% | 439 |
|
|
2021
Q3 | $64.7K | Sell |
400
-200
| -33% | -$32.3K | 0.01% | 495 |
|
|
2021
Q2 | $98.2K | Sell |
600
-1,419
| -70% | -$232K | 0.02% | 453 |
|
|
2021
Q1 | $304K | Sell |
2,019
-900
| -31% | -$136K | 0.06% | 267 |
|
|
2020
Q4 | $442K | Sell |
2,919
-57
| -2% | -$8.64K | 0.09% | 196 |
|
|
2020
Q3 | $403K | Buy |
+2,976
| New | +$403K | 0.1% | 210 |
|